Australian registered LARIAM® mefloquine 250 mg tablets are currently in limited availability. The TGA has granted Section 19A approval for temporary supply of Mefloquine Hydrochloride 250 mg tablets from Canada to ensure continuity of malaria treatment and prophylaxis. Pro Pharmaceuticals Group now supports supply to Australian healthcare institutions.

Pro Pharmaceuticals Group returns to WHX Dubai 2026 to meet existing global suppliers and customers and engage GCC organisations in clinical trial procurement and complex medicine access.

Praziquantel 600 mg tablets USP (Endo, USA) pack approved under TGA Section 19A

Fludarabine Phosphate Injection Section 19A